KONTENDAS Trademark

Trademark Overview

On Friday, June 12, 2015, a trademark application was filed for KONTENDAS with the United States Patent and Trademark Office. The USPTO has given the KONTENDAS trademark a serial number of 86661442. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2019. This trademark is owned by Neurocrine Biosciences, Inc.. The KONTENDAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, muscle dystonia, neurological-related movement disorders and involuntary tics resulting from neurological disorders
kontendas

General Information

Serial Number86661442
Word MarkKONTENDAS
Filing DateFriday, June 12, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, insomnia, endometriosis, uterine fibroids, tardive dyskinesia, Tourette syndrome, muscle dystonia, neurological-related movement disorders and involuntary tics resulting from neurological disorders
Translation of Words in MarkThe word "Kontendas" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 17, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, March 18, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, October 12, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 12, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 14, 2018EXTENSION 5 GRANTED
Monday, August 6, 2018EXTENSION 5 FILED
Tuesday, August 14, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 6, 2018TEAS EXTENSION RECEIVED
Thursday, December 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2017EXTENSION 4 GRANTED
Tuesday, December 12, 2017EXTENSION 4 FILED
Tuesday, December 12, 2017TEAS EXTENSION RECEIVED
Thursday, October 19, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 19, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2017EXTENSION 3 GRANTED
Tuesday, August 1, 2017EXTENSION 3 FILED
Tuesday, August 1, 2017TEAS EXTENSION RECEIVED
Wednesday, February 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2017EXTENSION 2 GRANTED
Monday, January 30, 2017EXTENSION 2 FILED
Monday, January 30, 2017TEAS EXTENSION RECEIVED
Friday, August 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 3, 2016EXTENSION 1 GRANTED
Wednesday, August 3, 2016EXTENSION 1 FILED
Wednesday, August 3, 2016TEAS EXTENSION RECEIVED
Tuesday, February 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 6, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 6, 2015ASSIGNED TO LIE
Monday, September 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 28, 2015EXAMINER'S AMENDMENT ENTERED
Monday, September 28, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 28, 2015EXAMINERS AMENDMENT E-MAILED
Monday, September 28, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 22, 2015ASSIGNED TO EXAMINER
Wednesday, June 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 16, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

kontendas neurological disorders related uterine fibroids endometriosis system diseases tardive insomnia